Sign Up to like & get
recommendations!
1
Published in 2021 at "International Journal of Rheumatic Diseases"
DOI: 10.1111/1756-185x.14246
Abstract: There is an unmet need for a reliable biomarker for the differentiation of axial spondyloarthritis (AxSpA) from its mimickers. Serum levels of interleukin‐22 (IL‐22) have previously been found to be significantly elevated in patients with…
read more here.
Keywords:
association elevated;
axial spondyloarthritis;
interleukin clinical;
elevated serum ... See more keywords